Russ Hawkinson

Sr. Vice President of Finance, Silverback Therapeutics.

Companies

Silverback TherapeuticsSr. Vice President of Finance Dec 3, 2020 to May 4, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Silverback Therapeutics SPRY37,251 shares²$159.6K at $4.29May 2, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

May 2, 2022Granted 28,335 shares of Silverback Therapeutics²
Feb 1, 2022Granted 7,500 shares of Silverback Therapeutics³
Dec 8, 2020Bought 200 shares at $21.00 of Silverback Therapeutics⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSilverback Therapeutics, Sr. Vice President of Finance
2
SEC EDGARSilverback Therapeutics shares after the filing of May 2, 2022
3
SEC EDGARForm 4 filed Feb 2, 2022
4
SEC EDGARForm 4 filed Feb 24, 2022